Today’s short video takes a closer look at Abbott Labs (ABT - Free Report) stock ahead of their earnings report. The company has seen extremely choppy trading as of late, and it will be up to this coming release to right the ship.
Fortunately for ABT investors, the stock has a great track record in earnings season which includes beats stretching back to 2013. The company also has a ‘B’ for its VGM score, so fundamentals are pretty strong for this stock as well.
However, investors should note that earnings estimate revisions have come in pretty weak as of late, pushing the stock down into ‘sell’ territory. Add in a bottom 20% industry rank, and this could be a name to stay away from this earnings season, at least until we see some better numbers on the earnings estimate and Zacks Rank fronts.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Today’s short video takes a closer look at Abbott Labs (ABT - Free Report) stock ahead of their earnings report. The company has seen extremely choppy trading as of late, and it will be up to this coming release to right the ship.
Fortunately for ABT investors, the stock has a great track record in earnings season which includes beats stretching back to 2013. The company also has a ‘B’ for its VGM score, so fundamentals are pretty strong for this stock as well.
However, investors should note that earnings estimate revisions have come in pretty weak as of late, pushing the stock down into ‘sell’ territory. Add in a bottom 20% industry rank, and this could be a name to stay away from this earnings season, at least until we see some better numbers on the earnings estimate and Zacks Rank fronts.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ABT - FREE